封面
市场调查报告书
商品编码
1550678

宠物糖尿病照护设备市场:依动物类型、解决方案、最终用户、地区

Pet Diabetes Care Devices Market, By Animal Type, By Solutions (Treatment, and Glucose Monitoring Devices), By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 166 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球宠物糖尿病护理设备市场规模为24.2亿美元,预计2031年将达到39.1亿美元,2024年至2031年的复合年增长率为7.1%。

报告范围 报告详情
基准年 2023年 2024年市场规模 24.2亿美元
实际资料 2019年至2023年 预测期 从2024年到2031年
预测 2024-2031 年复合年增长率: 7.10% 2031年价值预测 39.1亿美元
图:2024 年各地区宠物糖尿病照护设备市场占有率(%)
宠物糖尿病护理设备市场-IMG1

近年来,全球宠物糖尿病护理设备市场经历了显着成长。宠物肥胖率的上升和宠物的人性化程度不断提高,导致人们对宠物健康、预防保健和宠物疾病治疗的认识不断提高。宠物饲主积极监测血糖值,并透过注射胰岛素和治疗性饮食来控制宠物的糖尿病。人们已经开发出各种技术来实现宠物糖尿病管理的非侵入性监测和胰岛素管理。连续血糖监测 (CGM) 系统、胰岛素帮浦和采血笔的进步正在简化宠物的糖尿病治疗。宠物保险覆盖范围的扩大和宠物护理支出的增加也支撑了对宠物糖尿病护理设备的需求。然而,高昂的设备和处理成本是市场成长的主要挑战。

(市场动态):。

宠物肥胖率上升、开发中国家宠物拥有增加、宠物健康和疾病管理意识不断提高、新产品推出以及技术进步等关键因素正在推动全球宠物糖尿病护理设备市场的成长。然而,与血糖监测设备、治疗和兽医护理相关的高成本是阻碍这些技术广泛采用的主要因素。市场开拓公司致力于透过技术创新开发价格实惠的解决方案,以扩大新兴市场地区的基本客群。对宠物护理新兴企业的资金筹措的增加表明,不仅有进入开拓市场的机会,而且还有开发新解决方案的机会。

(本次调查的主要特点)

该报告对全球宠物糖尿病护理设备市场进行了详细分析,提供了以2023年为基准年的预测期(2024-2031年)的市场规模(十亿美元)和年复合成长率(CAGR%)。

它还揭示了各个细分市场的潜在商机,并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它根据公司亮点、产品系列、主要亮点、绩效和策略等参数,介绍了全球宠物糖尿病护理设备市场的主要企业。

本研究涵盖的主要企业包括Abbot Laboratories, Inc、Virbac、Medtronic plc、Johnson &Johnson Services, Inc、Roche Diagnostics、Bio-Rad Laboratories, Inc、Novo Nordisk A/S、Zoetis Inc、Terumo Corporation、Boehringer,其中包括Ingelheim International GmbH、IDEXX Laboratories、Johnson &Johnson Services, Inc.、Terumo Corporation、Eli Lilly and Company、Vetoquinol SA 和 i-SENS, Inc.

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过用于分析全球宠物糖尿病护理设备市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场预测

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章全球宠物糖尿病照护设备市场,依动物类型,2024-2031

第五章全球宠物糖尿病护理设备市场(按解决方案)2024-2031 年

  • 治疗
  • 胰岛素治疗
  • 血糖值监测装置

第六章 全球宠物糖尿病照护设备市场,依最终使用者划分,2024-2031 年

  • 兽医诊所
  • 家庭护理设置
  • 动物医院

第七章2019-2031年全球宠物糖尿病照护设备市场(按地区)

  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第八章 竞争格局

  • Abbot Laboratories, Inc
  • Virbac
  • Medtronic plc
  • Johnson & Johnson Services, Inc
  • Roche Diagnostics
  • Bio-Rad Laboratories, Inc
  • Novo Nordisk A/S
  • Zoetis Inc
  • Terumo Corporation
  • Boehringer Ingelheim International GmbH
  • IDEXX Laboratories
  • Johnson & Johnson Services, Inc
  • Terumo Corporation
  • Eli Lilly and Company
  • Vetoquinol SA
  • i-SENS, Inc.

第九章 分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第10章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7245

The global pet diabetes care devices market is estimated to be valued at USD 2.42 Billion in 2024 and is expected to reach USD 3.91 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 2.42 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 7.10% 2031 Value Projection: US$ 3.91 Bn
Figure. Pet Diabetes Care Devices Market Share (%), By Region 2024
Pet Diabetes Care Devices Market - IMG1

The global pet diabetes care devices market has been witnessing significant growth in the recent times. Rising pet obesity levels and increasing pet humanization have resulted in greater awareness about pet health, preventive care, and treatment of pet diseases. Pet owners are making active efforts towards monitoring blood glucose levels and managing diabetes in pets through insulin administration and therapeutic diet. Various technologies have been developed for diabetes management in pets which enables the non-invasive monitoring and administration of insulin doses. Advancements in continuous glucose monitoring (CGM) systems, insulin pumps, and lancing devices have simplified diabetes care for pets. Growing pet insurance coverage and rising pet care expenditure also supports the demand for specialized pet diabetes care devices. However, high cost of devices and therapy remains a key challenge for market growth.

(Market Dynamics):

Key factors, such as rising pet obesity, growing pet ownership in developing nations, increasing awareness about pet health and disease management, new product launches, and technological advancements, are fueling the growth of global pet diabetes care devices market. However, high cost associated with glucose monitoring devices, therapy and veterinary care is a major factor hampering the widespread adoption of these technologies. Market players are focusing on developing affordable solutions through innovations to expand their customer base in developing regions. Rising venture capital funding in pet care startups indicate strong opportunities for development of novel solutions as well as penetration in untapped markets.

(Key Features of the Study):

This report provides in-depth analysis of the global pet diabetes care devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global pet diabetes care devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbot Laboratories, Inc, Virbac, Medtronic plc, Johnson & Johnson Services, Inc, Roche Diagnostics, Bio-Rad Laboratories, Inc, Novo Nordisk A/S, Zoetis Inc, Terumo Corporation, Boehringer Ingelheim International GmbH, IDEXX Laboratories, Johnson & Johnson Services, Inc, Terumo Corporation, Eli Lilly and Company, Vetoquinol S.A., i-SENS, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global pet diabetes care devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pet diabetes care devices market.

Detailed Segmentation-

  • By Animal Type
    • Dogs
    • Cats
  • By Solutions
    • Treatment
    • Insulin Therapy
    • Insulin Delivery Devices
    • Other Treatments
    • Glucose Monitoring Devices
  • By End User
    • Veterinary Clinics
    • Home Care Settings
    • Veterinary Hospitals
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Key Players Insights
    • Abbot Laboratories, Inc
    • Virbac
    • Medtronic plc
    • Johnson & Johnson Services, Inc
    • Roche Diagnostics
    • Bio-Rad Laboratories, Inc
    • Novo Nordisk A/S
    • Zoetis Inc
    • Terumo Corporation
    • Boehringer Ingelheim International GmbH
    • IDEXX Laboratories
    • Johnson & Johnson Services, Inc
    • Terumo Corporation
    • Eli Lilly and Company
    • Vetoquinol S.A.
    • i-SENS, Inc.

Table of Contents

1. Research objectives and assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market preview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Pet Diabetes Care Devices Market, By Animal Type
    • Global Pet Diabetes Care Devices Market, By Solutions
    • Global Pet Diabetes Care Devices Market, By End User
    • Global Pet Diabetes Care Devices Market, By Region

3. Market dynamics, regulations, and trends analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Pet Diabetes Care Devices Market, By Animal Type, 2024-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Dogs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cats
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Pet Diabetes Care Devices Market, By Solutions, 2024-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Insulin Therapy
    • Insulin Delivery Devices
    • Other Treatments
  • Glucose Monitoring Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Pet Diabetes Care Devices Market, By End User, 2024-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Veterinary Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Veterinary Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Pet Diabetes Care Devices Market, By Region, 2019 - 2031, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
    • Regional Trends
      • North America
    • Introduction
  • U.S.
  • Canada
  • Latin America
    • Introduction
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
  • South Africa
  • North Africa
  • Central Africa

8. COMPETITIVE LANDSCAPE

  • Abbot Laboratories, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson Services, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novo Nordisk A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zoetis Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IDEXX Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson Services, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetoquinol S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • i-SENS, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us